放出制御型ドラッグデリバリーの世界市場レポート 2025年

放出制御型ドラッグデリバリーの市場規模は、今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）13.1％で1,194億1,000万米ドルに成長します。予測期間の成長は、個別化医療へのシフト、患者の利便性を高める技術統合、生物製剤とバイオシミラーの拡大、新興地域での市場拡大、ポリマー科学の進歩などに起因すると考えられます。予測期間における主な動向としては、生分解性・生体適合性材料、ナノテクノロジーの進歩、個別化医療と標的治療、移植可能デバイスの進歩、革新的なカプセル化技術などが挙げられます。

非感染性疾患（NCDs）とも呼ばれる慢性疾患の有病率の増加は、放出制御型ドラッグデリバリー市場拡大の重要な促進要因として作用すると予測されます。慢性疾患は、心臓病、がん、糖尿病などの疾病を包含し、長期にわたって持続するため、継続的な治療が必要となり、日常生活が制限されることが多くあります。放出制御型ドラッグデリバリーは、このような慢性疾患の治療において極めて重要な役割を果たしています。特に、長期の治療を必要とする患者や、ヘルスケアへのアクセスが限られている地域に住む患者にとっては、薬剤の徐放を容易にするドラッグデリバリー製剤が最も重要です。例えば、世界保健機関（WHO）が2022年9月に発表した報告書によると、年間4,100万人が慢性疾患で命を落としており、世界全体の死亡者数の74％を占めています。約1,700万人が70歳になる前に慢性疾患で命を落としています。さらに、慢性疾患に起因する死亡の77％は低・中所得国で発生しており、今後も増加が予想されます。このように、慢性疾患の有病率の高まりは、放出制御型ドラッグデリバリー市場の成長を後押ししています。

ヘルスケア支出の増加は、今後数年間の放出制御型ドラッグデリバリー市場の成長を促進すると予測されています。ヘルスケア支出は、特定の地域、国、または経済圏において、指定された時間枠の中でヘルスケア部門に割り当てられるすべての財源（公共および民間の両方）を含みます。ヘルスケアへの投資は、治療成績、患者のアドヒアランス、全体的なヘルスケア効率の向上を目的とした初期研究から市販後のモニタリングまで、医薬品のライフサイクル全体を含む多面的な取り組みです。例えば、2024年5月、英国の統計当局である国家統計局は、2023年の英国のヘルスケア支出は約2,920億ポンドで、名目上5.6％の増加を示したと報告しました。さらに、長期的な医療・社会保障支出は、2022年には実質2.8％の伸びを記録しました。このように、ヘルスケア支出の増加が放出制御型ドラッグデリバリー市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の放出制御型ドラッグデリバリー市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の放出制御型ドラッグデリバリー市場：成長率分析
• 世界の放出制御型ドラッグデリバリー市場の実績：規模と成長、2019～2024年
• 世界の放出制御型ドラッグデリバリー市場の予測：規模と成長、2024～2029年、2034年
• 世界の放出制御型ドラッグデリバリー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の放出制御型ドラッグデリバリー市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• Wurster技術
• コアセルベーション
• マイクロカプセル化
• インプラント
• 経皮
• ターゲットデリバリー
• その他
• 世界の放出制御型ドラッグデリバリー市場：放出メカニズム別、実績と予測、2019～2024年、2024～2029年、2034年
• ポリマーベースシステム
• マイクロリザーバーパーティション制御ドラッグデリバリーシステム
• フィードバック制御ドラッグデリバリーシステム
• 活性化調節ドラッグデリバリーシステム
• 化学的活性化
• 世界の放出制御型ドラッグデリバリー市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 定量吸入器
• 注射可能
• 経皮パッチと眼科用パッチ
• その他
• 世界の放出制御型ドラッグデリバリー市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 個人
• 研究
• その他
• 世界の放出制御型ドラッグデリバリー市場：Wurster技術のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• スプレーコーティング
• 流動層コーティング
• 世界の放出制御型ドラッグデリバリー市場：コアセルベーションのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 単純コアセルベーション
• 複合コアセルベーション
• 世界の放出制御型ドラッグデリバリー市場：マイクロカプセル化のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ポリマーベースのマイクロカプセル化
• 脂質ベースのマイクロカプセル化
• 世界の放出制御型ドラッグデリバリー市場：インプラントのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 生分解性インプラント
• 非生分解性インプラント
• 世界の放出制御型ドラッグデリバリー市場：経皮のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• マイクロニードルパッチ
• リザーバーシステム
• マトリックスシステム
• 世界の放出制御型ドラッグデリバリー市場：ターゲットデリバリーのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ナノ粒子
• 抗体薬物複合体
• リポソーム
• 世界の放出制御型ドラッグデリバリー市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 浸透圧ポンプ
• インサイチュゲル化システム

第7章 地域別・国別分析

• 世界の放出制御型ドラッグデリバリー市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の放出制御型ドラッグデリバリー市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 放出制御型ドラッグデリバリー市場：競合情勢
• 放出制御型ドラッグデリバリー市場：企業プロファイル
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Alkermes plc Overview, Products and Services, Strategy and Financial Analysis
  • Coating Place Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Corium International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Depomed Inc.
• Pfizer Inc.
• Aradigm Corporation
• Capsugel LLC
• GlaxoSmithKline plc
• Bayer Healthcare LLC
• Collegium Pharmaceuticals Inc.
• GE HealthCare Technologies Inc.
• Adare Pharmaceuticals Inc.
• Allergan plc
• Novartis AG
• Lonza Group AG
• Colorcon Inc.
• SKY Pharmaceuticals Pvt. Ltd.
• AstraZeneca plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 放出制御型ドラッグデリバリー市場2029年：新たな機会を提供する国
• 放出制御型ドラッグデリバリー市場2029年：新たな機会を提供するセグメント
• 放出制御型ドラッグデリバリー市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Controlled release drug delivery involves a dosage form designed to administer a medicine or medication in a specific manner, providing continuous and predictable kinetics for a predetermined duration.

The primary types of technology employed in controlled release drug delivery include the wurster technique, coacervation, microencapsulation, implants, transdermal delivery, targeted delivery, and others. The wurster technique, also known as fluid bed microencapsulation, encapsulates discrete particles in a fluidized bed using differential air flow to create cyclic movement of material. It encompasses various release mechanisms such as polymer-based systems, micro-reservoir partition-controlled drug delivery systems, feedback-regulated drug delivery systems, activation-modulated drug delivery systems, and chemically activated methods. These technologies find applications in metered dose inhalers, injectables, transdermal and ocular patches, among others. Major end-users include hospitals, clinics, individuals, research institutions, and others.

The controlled release drug delivery market research report is one of a series of new reports from The Business Research Company that provides controlled release drug delivery market statistics, including controlled release drug delivery industry global market size, regional shares, competitors with a controlled release drug delivery market share, detailed controlled release drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the controlled release drug delivery industry. This controlled release drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The controlled release drug delivery market size has grown rapidly in recent years. It will grow from $65.44 billion in 2024 to $73.01 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to pioneering drug delivery systems, early polymer-based formulations, introduction of microencapsulation techniques, emergence of transdermal delivery, regulatory approvals, and standardization.

The controlled release drug delivery market size is expected to see rapid growth in the next few years. It will grow to $119.41 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to shift towards personalized medicine, technological integration for patient convenience, expansion of biologics and biosimilars, market expansion in developing regions, advancements in polymer science. Major trends in the forecast period include biodegradable and biocompatible materials, nanotechnology advancements, personalized medicine and targeted therapies, advances in implantable devices, innovative encapsulation techniques.

The increasing prevalence of chronic diseases, also termed noncommunicable diseases (NCDs), is projected to act as a significant driver for the expansion of the controlled release drug delivery market. Chronic diseases, which encompass ailments such as heart disease, cancer, and diabetes, persist over extended periods, necessitating ongoing medical attention and often restricting daily activities. Controlled-release drug delivery plays a pivotal role in treating such chronic conditions. Particularly for patients requiring prolonged treatment or residing in areas with limited healthcare access, drug delivery formulations facilitating extended medication release are paramount. For instance, a September 2022 report shared by the World Health Organization (WHO) highlighted that annually, 41 million people succumb to chronic diseases, accounting for 74 percent of global fatalities. Approximately 17 million individuals lose their lives to chronic ailments before reaching the age of 70. Moreover, 77 percent of deaths attributed to chronic diseases occur in low- and middle-income countries, with anticipated future increases. Thus, the escalating prevalence of chronic diseases fuels the growth of the controlled release drug delivery market.

The rising healthcare expenditure is projected to drive the growth of the controlled release drug delivery market in the coming years. Healthcare spending encompasses all financial resources-both public and private-allocated to the healthcare sector within a specific geographic area, country, or economy during a designated time frame. Investment in controlled release drug delivery is a multifaceted endeavor that includes the entire lifecycle of a medicinal product, from initial research to post-market monitoring, aimed at enhancing treatment outcomes, patient adherence, and overall healthcare efficiency. For instance, in May 2024, the Office for National Statistics, a UK-based statistics authority, reported that healthcare expenditure in the UK was approximately £292 billion in 2023, marking a nominal increase of 5.6%. Furthermore, long-term health and social care spending experienced a real-term growth of 2.8% in 2022. Consequently, the increasing healthcare spending is driving the growth of the controlled release drug delivery market.

Technological progression stands out as a pivotal trend gaining traction within the controlled-release drug delivery market. Major enterprises operating in this sector are embracing novel technologies to fortify their market positions. For example, in March 2022, Evonik Industries AG, a Germany-based pharmaceutical company, introduced UDRATEC SoluFlow. This innovative microparticle technology is engineered to enhance the solubility of active medicinal constituents in oral medication formulations. Utilizing an emulsion-based processing technique, UDRATEC SoluFlow overcomes solubility barriers unattainable through traditional production methods. This addition to Evonik Health Care's suite of oral drug delivery system solutions complements existing offerings such as oral excipients such as EUDRAGIT functional polymers, ready-to-fill functional capsules such as EUDRACAPTM, and various technologies and services aimed at optimizing medication performance.

Leading entities within the chocolate syrup market are strategically engaging in partnership initiatives, with a focus on broadening applications in the ophthalmic field. Strategic partnerships denote a collaborative process wherein companies leverage each other's strengths and resources to achieve mutual benefits and foster success. For instance, in March 2023, Hovione, a Portugal-based contract drug manufacturing company, unveiled a collaboration with Ripple Therapeutics Inc. to expand the utilization of Ripple's Epidel technology beyond its current ophthalmic applications. This partnership marks a pivotal step in extending the Epidel platform's reach beyond ophthalmology, combining technical synergy, innovative vision, and a harmonious cultural alignment. Hovione's proficiency in regulated, sustained drug administration, coupled with their expertise in chemical synthesis and pharmaceutical manufacturing, forms a robust foundation for this collaboration. Ripple Therapeutics Inc. operates as a Canada-based pharmaceutical firm.

In November 2022, Alcon, a Switzerland-based pharmaceuticals and medical devices company, completed the acquisition of Aerie Pharmaceuticals, Inc. for an undisclosed sum. This strategic acquisition signifies an expansion of Alcon's diverse range of commercial products and development pipeline within the realm of ophthalmic pharmaceuticals. Aerie Pharmaceuticals, Inc., an esteemed US-based company specializing in the manufacture of ophthalmic solutions, further bolsters Alcon's portfolio and advancements in the ophthalmic pharmaceutical sector through this acquisition.

Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.

North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the controlled release drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The controlled release drug delivery market consists of revenues earned by entities by providing services such as mucoadhesive drug delivery, implantable drug delivery, and gastro-retentive drug delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. The controlled release drug delivery market also includes sales of nebulizers, infusion pumps, and other systems used to provide controlled release drug delivery. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Controlled Release Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on controlled release drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for controlled release drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The controlled release drug delivery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Wurster Technique; Coacervation; Micro Encapsulation; Implants; Transdermal; Targeted Delivery; Other Technologies
• 2) By Release Mechanism: Polymer Based Systems; Micro Reservoir Partition Controlled Drug Delivery Systems; Feedback Regulated Drug Delivery Systems; Activation-Modulated Drug Delivery Systems; Chemically Activated;
• 3) By Application: Metered Dose Inhalers; Injectable; Transdermal And Ocular Patches; Other Applications
• 4) By End User: Hospitals; Clinics; Personal; Research; Other End Users
• Subsegments:
• 1) By Wurster Technique: Spray Coating; Fluid Bed Coating
• 2) By Coacervation: Simple Coacervation; Complex Coacervation
• 3) By Micro Encapsulation: Polymer-Based Micro Encapsulation; Lipid-Based Micro Encapsulation
• 4) By Implants: Biodegradable Implants; Non-Biodegradable Implants
• 5) By Transdermal: Microneedle Patches; Reservoir Systems; Matrix Systems
• 6) By Targeted Delivery: Nanoparticles; Antibody-Drug Conjugates; Liposomes
• 7) By Other Technologies: Osmotic Pumps; In Situ Gelling Systems
• Companies Mentioned: Johnson & Johnson Services Inc.; Merck & Co. Inc.; Alkermes plc; Coating Place Inc.; Corium International Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Controlled Release Drug Delivery Market Characteristics

3. Controlled Release Drug Delivery Market Trends And Strategies

4. Controlled Release Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Controlled Release Drug Delivery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Controlled Release Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Controlled Release Drug Delivery Market Growth Rate Analysis
• 5.4. Global Controlled Release Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Controlled Release Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Controlled Release Drug Delivery Total Addressable Market (TAM)

6. Controlled Release Drug Delivery Market Segmentation

• 6.1. Global Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wurster Technique
• Coacervation
• Micro Encapsulation
• Implants
• Transdermal
• Targeted Delivery
• Other Technologies
• 6.2. Global Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymer Based Systems
• Micro Reservoir Partition Controlled Drug Delivery Systems
• Feedback Regulated Drug Delivery Systems
• Activation-Modulated Drug Delivery Systems
• Chemically Activated
• 6.3. Global Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered Dose Inhalers
• Injectable
• Transdermal and Ocular Patches
• Other Applications
• 6.4. Global Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Peronal
• Research
• Other End Users
• 6.5. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Wurster Technique, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spray Coating
• Fluid Bed Coating
• 6.6. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Coacervation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Simple Coacervation
• Complex Coacervation
• 6.7. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Micro Encapsulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymer-Based Micro Encapsulation
• Lipid-Based Micro Encapsulation
• 6.8. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biodegradable Implants
• Non-Biodegradable Implants
• 6.9. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Transdermal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microneedle Patches
• Reservoir Systems
• Matrix Systems
• 6.10. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Targeted Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nanoparticles
• Antibody-Drug Conjugates
• Liposomes
• 6.11. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Osmotic Pumps
• In Situ Gelling Systems

7. Controlled Release Drug Delivery Market Regional And Country Analysis

• 7.1. Global Controlled Release Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Controlled Release Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Controlled Release Drug Delivery Market

• 8.1. Asia-Pacific Controlled Release Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Controlled Release Drug Delivery Market

• 9.1. China Controlled Release Drug Delivery Market Overview
• 9.2. China Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Controlled Release Drug Delivery Market

• 10.1. India Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Controlled Release Drug Delivery Market

• 11.1. Japan Controlled Release Drug Delivery Market Overview
• 11.2. Japan Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Controlled Release Drug Delivery Market

• 12.1. Australia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Controlled Release Drug Delivery Market

• 13.1. Indonesia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Controlled Release Drug Delivery Market

• 14.1. South Korea Controlled Release Drug Delivery Market Overview
• 14.2. South Korea Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Controlled Release Drug Delivery Market

• 15.1. Western Europe Controlled Release Drug Delivery Market Overview
• 15.2. Western Europe Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Controlled Release Drug Delivery Market

• 16.1. UK Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Controlled Release Drug Delivery Market

• 17.1. Germany Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Controlled Release Drug Delivery Market

• 18.1. France Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Controlled Release Drug Delivery Market

• 19.1. Italy Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Controlled Release Drug Delivery Market

• 20.1. Spain Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Controlled Release Drug Delivery Market

• 21.1. Eastern Europe Controlled Release Drug Delivery Market Overview
• 21.2. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Controlled Release Drug Delivery Market

• 22.1. Russia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Controlled Release Drug Delivery Market

• 23.1. North America Controlled Release Drug Delivery Market Overview
• 23.2. North America Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Controlled Release Drug Delivery Market

• 24.1. USA Controlled Release Drug Delivery Market Overview
• 24.2. USA Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Controlled Release Drug Delivery Market

• 25.1. Canada Controlled Release Drug Delivery Market Overview
• 25.2. Canada Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Controlled Release Drug Delivery Market

• 26.1. South America Controlled Release Drug Delivery Market Overview
• 26.2. South America Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Controlled Release Drug Delivery Market

• 27.1. Brazil Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Controlled Release Drug Delivery Market

• 28.1. Middle East Controlled Release Drug Delivery Market Overview
• 28.2. Middle East Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Controlled Release Drug Delivery Market

• 29.1. Africa Controlled Release Drug Delivery Market Overview
• 29.2. Africa Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Controlled Release Drug Delivery Market Competitive Landscape And Company Profiles

• 30.1. Controlled Release Drug Delivery Market Competitive Landscape
• 30.2. Controlled Release Drug Delivery Market Company Profiles
  • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Alkermes plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Coating Place Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Corium International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Controlled Release Drug Delivery Market Other Major And Innovative Companies

• 31.1. Depomed Inc.
• 31.2. Pfizer Inc.
• 31.3. Aradigm Corporation
• 31.4. Capsugel LLC
• 31.5. GlaxoSmithKline plc
• 31.6. Bayer Healthcare LLC
• 31.7. Collegium Pharmaceuticals Inc.
• 31.8. GE HealthCare Technologies Inc.
• 31.9. Adare Pharmaceuticals Inc.
• 31.10. Allergan plc
• 31.11. Novartis AG
• 31.12. Lonza Group AG
• 31.13. Colorcon Inc.
• 31.14. SKY Pharmaceuticals Pvt. Ltd.
• 31.15. AstraZeneca plc

32. Global Controlled Release Drug Delivery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Controlled Release Drug Delivery Market

34. Recent Developments In The Controlled Release Drug Delivery Market

35. Controlled Release Drug Delivery Market High Potential Countries, Segments and Strategies

• 35.1 Controlled Release Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Controlled Release Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Controlled Release Drug Delivery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer